Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

542 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Expression of p60fyn in human platelets.
Horak ID, Corcoran ML, Thompson PA, Wahl LM, Bolen JB. Horak ID, et al. Among authors: thompson pa. Oncogene. 1990 Apr;5(4):597-602. Oncogene. 1990. PMID: 2183161
Mutant-selective AKT inhibition through lysine targeting and neo-zinc chelation.
Craven GB, Chu H, Sun JD, Carelli JD, Coyne B, Chen H, Chen Y, Ma X, Das S, Kong W, Zajdlik AD, Yang KS, Reisberg SH, Thompson PA, Lipford JR, Taunton J. Craven GB, et al. Among authors: thompson pa. Nature. 2024 Nov 6. doi: 10.1038/s41586-024-08176-4. Online ahead of print. Nature. 2024. PMID: 39506119
Correction: Statistical analysis plan for the SOLUTIONS randomised controlled trial with internal pilot: Solution Focused Brief Therapy (SFBT) in 10-17-year-olds presenting at police custody.
Thompson PA, Moody G, Coulman E, Owen-Jones E, Patel F, Gray KM, Hastings RP, Longman A, Lugg-Widger F, Segrott J, Badger J, Flynn S, Langdon PE, Playle R. Thompson PA, et al. Trials. 2024 Oct 13;25(1):675. doi: 10.1186/s13063-024-08529-4. Trials. 2024. PMID: 39396961 Free PMC article. No abstract available.
Statistical analysis plan for the SOLUTIONS randomised controlled trial with internal pilot: Solution Focused Brief Therapy (SFBT) in 10-17-year-olds presenting at policy custody.
Thompson PA, Moody G, Coulman E, Owen-Jones E, Patel F, Gray KM, Hastings RP, Longman A, Lugg-Widger F, Segrott J, Badger J, Flynn S, Langdon PE, Playle R. Thompson PA, et al. Trials. 2024 Sep 28;25(1):633. doi: 10.1186/s13063-024-08457-3. Trials. 2024. PMID: 39342238 Free PMC article.
Ending endless follow-up for low-risk CLL?
Thompson PA. Thompson PA. Blood Adv. 2024 Aug 27;8(16):4447-4448. doi: 10.1182/bloodadvances.2024012918. Blood Adv. 2024. PMID: 39190325 Free PMC article. No abstract available.
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in patients with B-cell malignancies: analysis of the Richter transformation subgroup from the multicentre, open-label, phase 1/2 BRUIN study.
Wierda WG, Shah NN, Cheah CY, Lewis D, Hoffmann MS, Coombs CC, Lamanna N, Ma S, Jagadeesh D, Munir T, Wang Y, Eyre TA, Rhodes JM, McKinney M, Lech-Maranda E, Tam CS, Jurczak W, Izutsu K, Alencar AJ, Patel MR, Seymour JF, Woyach JA, Thompson PA, Abada PB, Ho C, McNeely SC, Marella N, Nguyen B, Wang C, Ruppert AS, Nair B, Liu H, Tsai DE, Roeker LE, Ghia P. Wierda WG, et al. Among authors: thompson pa. Lancet Haematol. 2024 Sep;11(9):e682-e692. doi: 10.1016/S2352-3026(24)00172-8. Epub 2024 Jul 18. Lancet Haematol. 2024. PMID: 39033770 Clinical Trial.
542 results